Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


Articles published in J Clin Virol

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    December 2017
  1. LEINONEN MK, Schee K, Jonassen CM, Lie AK, et al
    Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
    J Clin Virol. 2017;99-100:22-30.
    PubMed     Text format     Abstract available


    February 2017
  2. GHOSH I, Muwonge R, Mittal S, Banerjee D, et al
    Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions.
    J Clin Virol. 2017;87:43-48.
    PubMed     Text format     Abstract available


    December 2016
  3. COOK DA, Smith LW, Law J, Mei W, et al
    Aptima HPV Assay versus Hybrid Capture(R) 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
    J Clin Virol. 2016;87:23-29.
    PubMed     Text format     Abstract available


    March 2016
  4. TAMALET C, Halfon P, Retraite LL, Grob A, et al
    Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France.
    J Clin Virol. 2016;78:102-107.
    PubMed     Text format     Abstract available


  5. JERONIMO J, Holme F, Slavkovsky R, Camel C, et al
    Implementation of HPV testing in Latin America.
    J Clin Virol. 2016;76 Suppl 1:S69-73.
    PubMed     Text format     Abstract available


  6. CAROZZI FM, Del Mistro A, Cuschieri K, Frayle H, et al
    HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.
    J Clin Virol. 2016;76 Suppl 1:S22-8.
    PubMed     Text format     Abstract available


  7. YAP D, Liang X, Garland SM, Hartley S, et al
    Clinicians' attitude towards changes in Australian National Cervical Screening Program.
    J Clin Virol. 2016;76 Suppl 1:S81-7.
    PubMed     Text format     Abstract available


  8. HAEDICKE J, Iftner T
    A review of the clinical performance of the Aptima HPV assay.
    J Clin Virol. 2016;76 Suppl 1:S40-8.
    PubMed     Text format     Abstract available


  9. POLJAK M, Kocjan BJ, Ostrbenk A, Seme K, et al
    Commercially available molecular tests for human papillomaviruses (HPV): 2015 update.
    J Clin Virol. 2016;76 Suppl 1:S3-S13.
    PubMed     Text format     Abstract available


    February 2016
  10. HORTLUND M, Sundstrom K, Lamin H, Hjerpe A, et al
    Laboratory audit as part of the quality assessment of a primary HPV-screening program.
    J Clin Virol. 2016;75:33-6.
    PubMed     Text format     Abstract available


    January 2016
  11. HESSELINK AT, Sahli R, Berkhof J, Snijders PJ, et al
    Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
    J Clin Virol. 2016;76:36-39.
    PubMed     Text format     Abstract available


  12. MAURER K, Luo H, Shen Z, Wang G, et al
    Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention.
    J Clin Virol. 2016;76:14-19.
    PubMed     Text format     Abstract available


    November 2015
  13. WENTZENSEN N, Schiffman M, Palmer T, Arbyn M, et al
    Triage of HPV positive women in cervical cancer screening.
    J Clin Virol. 2015 Nov 28. pii: S1386-6532(15)00749.
    PubMed     Text format     Abstract available


  14. POLJAK M, Ostrbenk A, Seme K, Sterbenc A, et al
    Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    J Clin Virol. 2015 Nov 19. pii: S1386-6532(15)00755.
    PubMed     Text format     Abstract available


  15. EL-ZEIN M, Richardson L, Franco EL
    Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
    J Clin Virol. 2015 Nov 18. pii: S1386-6532(15)00754.
    PubMed     Text format     Abstract available


  16. POLJAK M, Ginocchio CC
    Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
    J Clin Virol. 2015 Nov 5. pii: S1386-6532(15)00742.
    PubMed     Text format    


  17. JAYASINGHE Y, Rangiah C, Gorelik A, Ogilvie G, et al
    Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
    J Clin Virol. 2015 Nov 4. pii: S1386-6532(15)00734.
    PubMed     Text format     Abstract available


    June 2015
  18. LUTTMER R, Berkhof J, Dijkstra MG, van Kemenade FJ, et al
    Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    J Clin Virol. 2015;67:59-66.
    PubMed     Text format     Abstract available


    May 2015
  19. BRYANT D, Hibbitts S, Almonte M, Tristram A, et al
    Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
    J Clin Virol. 2015;66:66-71.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: